Notably, a recent study revealed that the expression of oncogenic HRASG12V, along with p16INK4a knockdown, in EnSCs induced high-grade endometrial stromal sarcoma in mice [34]. The gene discussed is CDKN2A; the disease is endometrioid stromal sarcoma.